The store will not work correctly when cookies are disabled.
6-Amino-5-(1-(4-chlorophenyl)ethoxy)-1'-methyl[3,4'-bipyridin]-2'(1'H)-one
ID: ALA4557900
PubChem CID: 155554593
Max Phase: Preclinical
Molecular Formula: C19H18ClN3O2
Molecular Weight: 355.83
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(Oc1cc(-c2ccn(C)c(=O)c2)cnc1N)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C19H18ClN3O2/c1-12(13-3-5-16(20)6-4-13)25-17-9-15(11-22-19(17)21)14-7-8-23(2)18(24)10-14/h3-12H,1-2H3,(H2,21,22)
Standard InChI Key: PTSWTAUGLDMBJZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
16.4274 -11.7622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4263 -12.5896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1411 -13.0024 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8575 -12.5891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8547 -11.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1393 -11.3495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7137 -11.3455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7154 -10.5196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0050 -10.1074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2882 -10.5165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2864 -11.3425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0014 -11.7592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5727 -13.0005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0079 -9.2824 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5675 -11.3435 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5645 -10.5185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2773 -10.1033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8484 -10.1087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9886 -10.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7010 -10.1021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6984 -9.2762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9773 -8.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2678 -9.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5752 -10.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4107 -8.8601 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
1 7 1 0
4 13 1 0
9 14 2 0
5 15 1 0
15 16 1 0
16 17 1 0
16 18 1 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
10 24 1 0
21 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 355.83 | Molecular Weight (Monoisotopic): 355.1088 | AlogP: 3.82 | #Rotatable Bonds: 4 |
Polar Surface Area: 70.14 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.97 | CX LogP: 2.89 | CX LogD: 2.88 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.77 | Np Likeness Score: -0.82 |
References
1. Chen W, Guo X, Zhang C, Ke D, Zhang G, Yu Y.. (2019) Discovery of 2-aminopyridines bearing a pyridone moiety as potent ALK inhibitors to overcome the crizotinib-resistant mutants., 183 [PMID:31569004] [10.1016/j.ejmech.2019.111734] |